Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
JCO Precision Oncology|July 7, 2022
Matched Molecular Profiling of Cell-Free DNA and Tumor Tissue in Patients With Advanced Clear Cell Renal Cell CarcinomaRitesh R Kotecha, Erika Gedvilaite, Ryan Ptashkin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2022
Deciphering radiological stable disease to immune checkpoint inhibitorsJ Luo, S Wu, H Rizvi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2021
Comprehensive Molecular Characterization and Response to Therapy in Fumarate Hydratase-Deficient Renal Cell CarcinomaJack P Gleeson, Ines Nikolovski, Renzo Dinatale, et al.
European Urology Focus|March 2, 2023
Cytoreductive Nephrectomy for Patients with Metastatic Sarcomatoid and/or Rhabdoid Renal Cell Carcinoma Treated with Immune Checkpoint TherapyAndrew W Hahn, Ritesh R Kotecha, Paul V Viscuse, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 17, 1998
The contribution of classical (beta1/2-) and atypical beta-adrenoceptors to the stimulation of human white adipocyte lipolysis and right atrial appendage contraction by novel beta3-adrenoceptor agonists of differing selectivitiesM V Sennitt, A J Kaumann, P Molenaar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 30, 2020
Comprehensive Genomic Analysis of Translocation Renal Cell Carcinoma Reveals Copy-Number Variations as Drivers of Disease ProgressionJulian Marcon, Renzo G DiNatale, Alejandro Sanchez, et al.
Science (New York, N.Y.)|February 26, 2026
Sensitive CAR T cells redefine targetable CD70 expression in solid tumorsSophie A Hanina, Tyler Park, Michael Lopez, et al.
JCO Oncology Practice|May 11, 2022
Implementation Strategies to Increase Clinical Trial Enrollment in a Community-Academic Partnership and Impact on Hispanic Representation: An Interrupted Time Series AnalysisNahomy Ledesma Vicioso, Diana Lin, Daniel R Gomez, et al.
European Urology|November 5, 2025
MLH1 Mismatch Repair Deficiency Predicts Exceptional Response to Immune Checkpoint Inhibition in Clear-cell Renal Cell CarcinomaMark T Dawidek, Lina Posada Calderon, Parantu K Shah, et al.
Nature Communications|November 14, 2025
The SLC1A1/EAAT3 dicarboxylic amino acid transporter is an epigenetically dysregulated nutrient carrier that sustains oncogenic metabolic programsTreg Grubb, Pooneh Koochaki, Sayed Matar, et al.
Pageof 8